A detailed history of Massachusetts Financial Services CO transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 260,687 shares of ORGO stock, worth $727,316. This represents 0.0% of its overall portfolio holdings.

Number of Shares
260,687
Previous 261,262 0.22%
Holding current value
$727,316
Previous $1.07 Million 30.71%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$2.61 - $4.49 $1,500 - $2,581
-575 Reduced 0.22%
260,687 $740,000
Q4 2023

Feb 08, 2024

SELL
$1.97 - $4.21 $16,256 - $34,740
-8,252 Reduced 3.06%
261,262 $1.07 Million
Q3 2023

Nov 08, 2023

SELL
$2.34 - $4.43 $24,167 - $45,753
-10,328 Reduced 3.69%
269,514 $857,000
Q2 2023

Aug 09, 2023

SELL
$1.9 - $4.3 $12,528 - $28,354
-6,594 Reduced 2.3%
279,842 $929,000
Q1 2023

May 10, 2023

SELL
$1.89 - $2.93 $15,307 - $23,730
-8,099 Reduced 2.75%
286,436 $610,000
Q4 2022

Feb 13, 2023

BUY
$2.48 - $3.43 $15,460 - $21,382
6,234 Added 2.16%
294,535 $792,000
Q3 2022

Nov 09, 2022

SELL
$3.14 - $6.43 $8,248 - $16,891
-2,627 Reduced 0.9%
288,301 $934,000
Q2 2022

Aug 09, 2022

BUY
$4.74 - $8.15 $6,967 - $11,980
1,470 Added 0.51%
290,928 $1.42 Million
Q1 2022

May 11, 2022

BUY
$6.47 - $9.57 $249,069 - $368,406
38,496 Added 15.34%
289,458 $2.21 Million
Q4 2021

Feb 10, 2022

BUY
$9.02 - $13.5 $815,922 - $1.22 Million
90,457 Added 56.36%
250,962 $2.32 Million
Q3 2021

Nov 10, 2021

BUY
$13.71 - $17.18 $351,277 - $440,185
25,622 Added 19.0%
160,505 $2.29 Million
Q2 2021

Aug 13, 2021

BUY
$14.92 - $23.23 $1.53 Million - $2.38 Million
102,563 Added 317.34%
134,883 $2.24 Million
Q1 2021

May 13, 2021

BUY
$7.33 - $21.06 $236,905 - $680,659
32,320 New
32,320 $589,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $365M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.